22-May-2007 - Biopharma firm QLT has decided to shed a chunk of its Atrigel drug delivery products and platform in a bid to improve profitability at the company.
22-May-2007 - US company Alnylam Pharmaceuticals has consolidated its relationship with researchers from the Massachusetts Institute of Technology (MIT) by signing an agreement to sponsor a five-year program at the Institute's Center for Cancer Research, focused on the delivery of therapeutics based on RNAi interference.
21-May-2007 - A live attenuated replication-defective vaccine against the influenza virus has started a Phase I clinical trial at the Medical University of Vienna in Austria.
17-May-2007 - US company Digestive Care (DCI) is quadrupling its manufacturing, research and development capacity following an increase in demand for its drug Pancrecarb (pancrelipase).
16-May-2007 - Bacterially derived nanocells that can deliver chemotherapeutic drugs directly to cancer cells without the shortcomings of liposomal or viral carriers could be in clinical trials by the end of this year, an Australian biotechnology company says.
15-May-2007 - Larger, high-value, reusable containers will drive demand for rigid packaging by 3.5 per cent each year, reaching $6.6bn in 2011, according to a new report.
15-May-2007 - It might look like a simple breath freshener dissolving mouth-strip but the John Hopkins University innovation is just steps away from cutting costs and saving thousands of lives from the deadly rotavirus.
15-May-2007 - The market's first nebulized form of formoterol fumarate for chronic obstructive pulmonary disease (COPD) has been given the go ahead by the US Food and Drug Administration (FDA).
15-May-2007 - A transdermal patch for needle-free delivery of insulin and a diagnostic test for rapid detection of meningococcal disease are among the products under development by two new Australian companies set up to commercialise the research outcomes of Nanotechnology Victoria (NanoVic).
15-May-2007 - A French firm developing an innovative gene delivery tool has received a cash boost of €80,000 to ramp up good manufacturing processes for its synthetic delivery molecule.
14-May-2007 - Midatech, the UK group exploring the therapeutic and diagnostic applications of nanoparticles as drug delivery vehicles, scaffolds for synthetic vaccines or antibiotics and non-invasive imaging agents, is hoping to put its first product into clinical trials in 2008.
10-May-2007 - Schwarz Pharma's foray into the central nervous system disorder market is beginning to pay serious dividends as the firm's ground-breaking transdermal patch for Parkinson's continues to prove a success story, now gaining approval in the US market.
09-May-2007 - The UK's Midatech Group has opened what it describes as "the world's first cGMP-grade manufacturing plant for the production of nanoparticles at a scale commensurate with pharmaceutical applications".
02-May-2007 - US diabetics will soon have a new alternative to the predominant needle and syringe method of administering insulin, now that the Food and Drug Administration (FDA) has granted marketing approval to Sanofi-Aventis' Lantus SoloStar.
02-May-2007 - West Pharmaceutical Services reported a 40 per cent increase in operating profit for the first quarter of 2007, despite profits diving 43 per cent in the Tech Group business that makes the delivery device for Pfizer's inhaled insulin Exubera.
02-May-2007 - Active packaging specialist Multisorb Technologies is in the midst of developing a new desiccant product that will offer a novel built-in solution to producers of dry powder and metered dose inhalers.
02-May-2007 - South African researchers have provided a glimmer of hope for the millions of people in the developing world struck down by tuberculosis (TB) by developing a nano-sized drug delivery platform that could make all the difference in the battle against drug resistant forms of the disease.
02-May-2007 - A 'homing' protein fragment that can track down tumours in the body has been developed to deliver imaging agents or anticancer therapies to cells.
26-Apr-2007 - Paladin Labs has reached an agreement in principle to acquire the outstanding shares of BioEnvelop Inc, which develops, manufactures and markets rapidly dissolving edible films for use as delivery systems in the pharmaceutical and nutraceutical sectors.
26-Apr-2007 - Dutch company OctoPlus has extended its rights to the PolyActive delivery technology used in its lead drug candidate Locteron, based on interferon alfa.
25-Apr-2007 - A novel buccal patch formulation of the opioid painkiller fentanyl is on track to be filed for approval in the third quarter of this year, following encouraging efficacy data from a Phase III trial.
25-Apr-2007 - French company Roquette has been awarded a US patent for a dissolve-in-the-mouth drug delivery technology that makes use of its novel StarLac excipient.
24-Apr-2007 - UK firm Futura Medical is in the running for a second license contract for one of its drug delivery platforms after pharma heavyweight GlaxoSmithKline came to the table to discuss terms.
23-Apr-2007 - A nasal powder flu vaccine is one step closer as DelSite Biotechnologies announces that it has found an antigen to use with its novel drug delivery system.
23-Apr-2007 - A new market-oriented approach to product development, more favourable licensing arrangements, strategic acquisitions and a fresh crop of proprietary drug-delivery technologies helped UK company BioProgress to deliver an adjusted operating profit for the first time in its history in the year to 31 December 2006.